Sebastien Latapie is a seasoned professional in venture capital and business development with a robust background in biochemistry and microbiology. Currently serving as a Partner and Principal at Avant Bio, Sebastien is involved in investing in therapeutic enabling technology and health tech companies. Additional roles include Board Member at PathPresenter and Board Observer positions at multiple firms including Alpenglow Biosciences, Curi Bio, Lucid Scientific, and CellFE. Previously, Sebastien held the position of Principal and Senior Venture Associate at Dynamk Capital LLC and worked at Northzone, managing growth strategies and innovation capabilities at New Markets Advisors. Educational qualifications include an MBA from Columbia Business School and advanced degrees from McGill University.
This person is not in any teams
Avant Bio LLC
3 followers
AVANT BIO LLC, a pioneering early stage and growth equity firm, announces its official launch, positioning itself at the forefront of today's transformative landscape in life sciences, tech bio, and healthtech industries. The Firm's investments align with the convergence of groundbreaking technologies and an enhanced understanding of biology, creating a powerful synergy poised for breakthrough advancements in the future.